机器人辅助腹腔镜与开腹手术在高危子宫内膜癌患者肾下腹主动脉旁淋巴结切除术中的比较:一项随机对照试验
该随机对照试验纳入120例疑似I-II期高危子宫内膜癌患者,比较机器人辅助腹腔镜手术(RALS)与开腹手术(LT)在肾下腹主动脉旁淋巴结清扫中的效果。RALS在腹主动脉旁淋巴结数量上非劣于LT,两组并发症和再入院无差异,RALS手术时间更长但出血更少、住院更短、总费用更低。作者认为RALS是局限于子宫的高危子宫内膜癌的有效治疗方式。
要点
- RALS腹主动脉旁淋巴结数量非劣于LT(均数差-1.6,95%CI -5.78至2.57)。
- RALS盆腔淋巴结数量低于LT(28±10 vs 22±8,p<0.001)。
- RALS手术时间更长但出血更少、住院更短、总费用更低。
核心结论
- RALS在腹主动脉旁淋巴结数量上非劣于LT,并发症率相当,住院时间更短且总费用更低。
- 该结果的普遍性需要高手术量和高度熟练的手术技巧。
- 对于局限于子宫的高危子宫内膜癌女性,RALS是一种有效的治疗方式。
研究设计与样本
- 随机对照试验,纳入120例组织学证实的子宫内膜癌、疑似I-II期且具有高危肿瘤特征的患者,随机分配至RALS或LT组接受子宫切除术、双侧输卵管卵巢切除术、盆腔和腹主动脉旁淋巴结切除术。
- 主要结局为腹主动脉旁淋巴结数量,次要结局为围手术期事件、术后并发症和总医疗费用。
- 符合方案分析纳入96例患者。
主要发现
- 腹主动脉旁淋巴结数量均值(±SD)RALS组为20.9(±9.6),LT组为22(±11),p=0.45;均数差为-1.6(95%CI -5.78至2.57),在非劣效界值内。
- 盆腔淋巴结数量均值RALS组为28±10,LT组为22±8,p<0.001。
- 两组围手术期并发症或再入院无差异。
- RALS组手术时间更长(p<0.001),但总出血量更少(p<0.001),住院时间更短(p<0.001)。
- RALS组医疗费用显著更低(均数差1568美元/1225欧元,p<0.05)。
关键数值与推荐
- RALS对比LT的腹主动脉旁淋巴结数量均数差为-1.6(95%CI -5.78至2.57),符合非劣效性。
- RALS组盆腔淋巴结数量均值28±10,LT组22±8,p<0.001。
- RALS组医疗费用均数差为1568美元/1225欧元,p<0.05。
临床怎么用
- 作者认为,对于局限于子宫的高危子宫内膜癌女性,RALS是一种有效的治疗方式。
- 作者指出该结果的普遍性需要高手术量和高度熟练的手术技巧。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate if robot-assisted laparoscopic surgery (RALS) was non-inferior to laparotomy (LT) in harvesting infrarenal paraaortic lymph nodes in patients with presumed stage I-II high-risk endometrial cancer. PATIENTS AND METHODS: Patients with histologically proven endometrial cancer, presumed stage I-II with high-risk tumour features, were randomised to hysterectomy, bilateral salpingo-oophorectomy, pelvic and paraaortic lymphadenectomy by either RALS or LT. Primary outcome was paraaortic lymph node count. Secondary outcomes were perioperative events, postoperative complications and total health care cost. RESULTS: Overall 120 patients were randomised and 96 patients were included in the per protocol analysis. Demographic, clinical and tumour characteristics were evenly distributed between groups. Mean (±SD) paraaortic lymph node count was 20.9 (±9.6) for RALS and 22 (±11, p = 0.45) for LT. The difference of means was within the non-inferiority margin (-1.6, 95% CI -5.78, 2.57). Mean pelvic node count was lower after RALS (28 ± 10 versus 22 ± 8, p < 0.001). There was no difference in perioperative complications or readmissions between the groups. Operation time was longer (p < 0.001) but total blood loss less (<0.001) and hospital stay shorter (<0.001) in RALS group than LT group. Health care costs for RALS was significantly lower (mean difference $1568 USD/€1225 Euro, p < 0.05). CONCLUSION: Our results demonstrate non-inferiority in paraaortic lymph node count, comparable complication rates, shorter hospital length and lower total cost for RALS over laparotomy. Generalisability of the latter finding requires a high-volume setting and high surgical proficiency. In women with high-risk endometrial cancer confined to the uterus, RALS is a valid treatment modality. CLINICAL TRIALS REGISTRATIONS: ClinicalTrials.govNCT01847703.
引用
- Salehi S, Åvall-Lundqvist E, Legerstam B, et al. Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial. Eur J Cancer. 2017. PMID: 28463759. doi:10.1016/j.ejca.2017.03.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。